Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.39 | €3.60 | 159.675% |
| Cerus Corp. | 4 | 0 | 2 | 0 | €1.69 | €3.26 | 92.795% |
| Madrigal Pharmaceuticals inc. | 4 | 0 | 1 | 0 | €217.90 | €315.00 | 44.562% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.22 | €19.86 | 219.628% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.56 | €5.00 | 9.649% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €25.60 | €26.58 | 3.834% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.18 | €10.00 | 22.249% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €45.36 | €70.00 | 54.338% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.76 | €4.39 | 149.506% |
| Radnet Inc. | 7 | 3 | 0 | 0 | €48.40 | €50.90 | 5.159% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 1 | 1 | €4.62 | €12.80 | 177.089% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.39 | €61.56 | 15765.747% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €15.33 | - | - |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.32 | €8.36 | 151.966% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 0 | 0 | €50.50 | €57.50 | 13.861% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €205.00 | - | - |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €4.02 | €8.27 | 105.780% |
| Immunic Inc. | 6 | 3 | 0 | 2 | €1.26 | €5.48 | 336.102% |
| Phibro Animal Health Corp. A | 4 | 1 | 0 | 0 | €15.70 | €13.89 | -11.521% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €7.38 | €10.00 | 35.501% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.93 | €5.51 | 490.428% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |
| Edap Tms S.A. ADR | 3 | 1 | 0 | 0 | €6.50 | €14.79 | 127.569% |